Abstract

Bronchial epithelial cells are front sentinels eliciting innate and adaptive immunity to respiratory viral pathogens. Recognition of viral double-stranded RNA induces antiviral interferon (IFN) responses in bronchial epithelial cells. Co-inhibitory molecules programmed cell death 1 ligand 1 (PD-L1) and ligand 2 (PD-L2) were also induced on bronchial epithelial cells, which bind programmed cell death 1 on T cell and inhibit the function of virus-specific cytotoxic T lymphocyte. A previous study showed that antiviral type I IFN increased PD-L1 and PD-L2 expression in cultured melanoma cells. However, it remains unknown whether antiviral IFNs affect PD-L1 and PD-L2 expression in bronchial epithelial cells. In addition, we previously reported that inhibition of PI3Kδ signaling enhanced antiviral IFN responses in human primary bronchial epithelial cells (PBECs). Here we assessed the effect of exogenous IFNs or a selective PI3Kδ inhibitor IC87114 on PD-L1 and PD-L2 in PBECs stimulated with a synthetic double-stranded RNA poly I:C or human metapneumovirus. Treatment with IFNβ or IFNλ increased PD-L1 and PD-L2, and IFNβ or IFNλ treatment plus poly I:C further increased both expressions. Treatment with IC87114 or transfection with siRNA targeting PI3K p110δ enhanced poly I:C–induced gene and protein expression of PD-L2, whereas IC87114 suppressed poly I:C–induced PD-L1. IC87114 enhanced poly I:C–induced gene expression of IFNβ, IFNλ, and IFN-regulated genes via increased TBK1 and IRF3 phosphorylation. Transfection with siIRF3 counteracted the enhancement of poly I:C–induced PD-L2 by IC87114, whereas IC87114 suppressed poly I:C–induced PD-L1 regardless of transfection with siNC or siIRF3. Similar effects of IC87114 on PD-L1 and PD-L2 expression were observed in human metapneumovirus–infected PBECs. We showed for the first time that type I and type III IFNs induced the expression of PD-L1 and PD-L2 in PBECs. Our findings suggest that during viral infections, inhibition of PI3Kδ differentially regulates PD-L1 and PD-L2 expression in bronchial epithelial cells.

Highlights

  • Programmed cell death 1 ligand 1 (PD-L1) and ligand 2 (PD-L2) are ligands of the programmed cell death 1 (PD-1) co-inhibitory receptor on T cells

  • We previously showed that viral infection or stimulation with a synthetic double-stranded RNA (dsRNA) analog, polyinosinic-polycytidylic acid, increased programmed cell death 1 ligand 1 (PD-L1) and PD-L2 expression on human bronchial epithelial cells, and the NF-kB pathway plays an essential role in poly I:C–induced upregulation of PD-L1 [12,13,14]

  • IFNl1 or poly I:C alone increased the expression of PD-L1 and PD-L2 on primary bronchial epithelial cells (PBECs) at 24 h after stimulation, and further upregulation of PD-L1 and PD-L2 was observed after the combination treatment of IFNl1 plus poly I:C (Figure S1A)

Read more

Summary

Introduction

Programmed cell death 1 ligand 1 (PD-L1) and ligand 2 (PD-L2) are ligands of the programmed cell death 1 (PD-1) co-inhibitory receptor on T cells. In respiratory virus infections, such as human metapneumovirus (hMPV) or influenza virus infection, inhibition of the PD-1/PD-L1 pathway restored virus-specific CD8+ T cell activity and resulted in faster virus clearance in lungs, which suggests that PD-L1 upregulation on infected cells is responsible for CD8+ T cell exhaustion [2, 4, 5]. Studies have shown that the expression of PD-L2 is induced in bronchial epithelial cells following viral infection such as respiratory syncytial virus [6], the precise role of PD-L2 in the antiviral immune response remains unknown. We previously showed that viral infection or stimulation with a synthetic dsRNA analog, polyinosinic-polycytidylic acid (poly I: C), increased PD-L1 and PD-L2 expression on human bronchial epithelial cells, and the NF-kB pathway plays an essential role in poly I:C–induced upregulation of PD-L1 [12,13,14]. While type I and III IFNs are induced as the first line response against respiratory viral infection, the effect of antiviral IFNs on the expression of PD-L1 and PD-L2 in bronchial epithelial cells has not been investigated

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call